Boston, MANCT07033208Now EnrollingIRB Ready

Crohn Disease Clinical Trial in Boston, MA

Access cutting-edge crohn disease treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.

Sponsored by Massachusetts General Hospital

Quick Self-Assessment

See if you qualify for this Boston location

Preparing your pre-screening questions…

Expert Care in Boston

Access crohn disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related crohn disease treatment provided free

Apply for This Boston Location

Check if you qualify for this crohn disease clinical trial in Boston, MA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Boston

    Convenient for MA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Boston site if eligible
  4. 4Begin participation

About This Crohn Disease Study in Boston

The goal of this research is to learn how a new device called the wireless thermal capsule (WTC) can collect thermal data to help see diseases that happen in the gastrointestinal (GI) tract, such as Crohn's Disease.

Sponsor: Massachusetts General Hospital

Who Can Participate

Inclusion Criteria

Participant is 18 -75 years old
Participant is considered healthy, with no known illnesses
Participant can follow fasting requirements
Participant can follow bowel prep instructions
Participant can provide informed consent

Exclusion Criteria

Participant is older than 75 years of age
Participant with current dysphagia or any swallowing disorder
Participant with any current condition believed to have an increased risk of capsule retention such as gastrointestinal strictures, intestinal tumors, bowel obstruction, incomplete colonoscopies or fistula
Participant with a diagnosis of gastroparesis or small bowel or large bowel dysmotility
Participant with a history of inflammatory bowel disease (IBD), intestinal Crohn's disease, chronic constipation, or rectal bleeding
Participant with clinical evidence of renal disease, including clinically significant laboratory abnormalities of renal function within the past 6 months
Participant with chronic usage of nonsteroidal anti-inflammatory drugs (NSAIDs)
Participants with a known contradiction to metoclopramide
Participants with a known contraindication to polyethylene glycol
Participant with currently suspected or diagnosed with hematochezia, melena, iron deficiency with or without anemia
Participant who has had intestinal surgery in the past
Participant with a history of congestive heart failure
Participant with Type I or Type II Diabetes
Participant has a cardiac pacemaker or other implanted electromedical device.
Participant expected to undergo MRI examination within 7 days after ingestion of the capsule.
Participant has participated in an investigational drug or device research study within 30 days of enrollment that may interfere with the subject's safety or ability to participate in this study
Participant with delayed gastric emptying
Participant who is pregnant, suspected pregnant, or is actively breast-feeding.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Boston?

Yes, this clinical trial (NCT07033208) has an active research site in Boston, MA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Crohn Disease Treatment Options in Boston, MA

If you're searching for crohn disease treatment options in Boston, MA, this clinical trial (NCT07033208) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced crohn disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all crohn disease clinical trials near you to find additional studies recruiting in your area.

More Crohns Disease Trials in Boston, MA

See all crohns disease clinical trials recruiting in Boston — not just this study.

Browse Crohns Disease Trials in Boston →

Browse More Trials by Condition

Crohns Disease TrialsAnkylosing Spondylitis TrialsAll Conditions →

Ready to Join in Boston?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Boston, MA